Companies · Other

Clade & Co., Inc.

NEW YORK · Other

Diligence memoA one-page analyst read on Clade & Co., Inc. — recommendation, valuation, rhythm, risks.→
$15.7M
Total raised · real
1
Rounds
—
Latest step-up
Top 18%
Sector rank · raised
Series B
Latest stage · inferred · Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Clade & Co., Inc. looks fair against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.69× the median modeled value of Series B Other companies in 2022–2024 (465 peers) — value vs value, same stage and era.
  • Within the normal band (69% of peer median) for its niche.
At-risk
  • Last raise 2.4 yr ago; this sector typically re-raises about every 11 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other

Clade & Co., Inc. is one of 25015 Other companies tracked from NEW YORK. By capital raised it ranks in the upper tier (ahead of 83% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
32
Investors (latest)
2024-01-22
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeries B · 2024-01-22 Raised $16M (real) Modeled valuation $108M (est)$16M$108MSeries B2024

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$15.7M · 2024

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 25%.

Modeled valuation trajectory
$108.4M
Base estimate est.
$39.3M
Conservative case
$211.2M
Upside case
$87.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series B — a $15M–$40M round). Valuation is modeled from stage benchmarks. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
68%
Survival probability
45% low · 83% high
1.28×/yr
Annual markup
1.55×/yr upside case
2.4 yr
Elapsed time used
2.4 yr actual, capped for stale marks
general
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
—
Avg between rounds
—
Capital velocity
2.7 yr
On record since
2024
First round
1
Rounds on file
How it compares to the market

Benchmarked against 25015 companies in Other. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages)▲ 7.7× above median
This company$15.7M
Sector median$2.0M
Latest round — vs other Series B rounds in sector (real $, this stage)▼ 0.8× of median
This company$15.7M
Sector median$19.6M
Modeled value — vs sector median (estimate, all stages)▲ 6.1× above median
This company$108.4M
Sector median$17.7M

Raised more than 83% of sector peers (real $). Modeled value above 84% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #332 of 465.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)Ever/Body, Inc. · Series B Raised $64.2M · modeled $430.5M (est)Financeware Holdings LLC · Series B Raised $59.7M · modeled $413.3M (est)American Cricket Enterprises Inc. · Series B Raised $39.0M · modeled $409.5M (est)Xlerate Ultimate Holdings, Lp · Series B Raised $62.2M · modeled $406.2M (est)MDME Ultimate Holdings, LP · Series B Raised $39.9M · modeled $395.7M (est)aXiomatic, LLC · Series B Raised $138.8M · modeled $389.6M (est)Moov Financial, Inc. · Series B Raised $69.2M · modeled $378.6M (est)NovaVision Holdings, LLC · Series B Raised $38.4M · modeled $374.2M (est)Ttxa Ii 2022, Lp · Series B Raised $35.0M · modeled $369.6M (est)Encamp, Inc. · Series B Raised $54.0M · modeled $363.4M (est)JAF Communications Holdings, LLC · Series B Raised $36.8M · modeled $358.9M (est)Enboarder Inc. · Series B Raised $39.7M · modeled $357.3M (est)Clade & Co., Inc. (this company) Raised $15.7M · modeled $108.4M (est)Clade & Co., Inc.
CompanyStageRaised · realValue · estvs peer med.
Ever/Body, Inc.Series B$64.2M$430.5M2.73×
Financeware Holdings LLCSeries B$59.7M$413.3M2.62×
American Cricket Enterprises Inc.Series B$39.0M$409.5M2.59×
Xlerate Ultimate Holdings, LpSeries B$62.2M$406.2M2.57×
MDME Ultimate Holdings, LPSeries B$39.9M$395.7M2.51×
aXiomatic, LLCSeries B$138.8M$389.6M2.47×
Moov Financial, Inc.Series B$69.2M$378.6M2.40×
NovaVision Holdings, LLCSeries B$38.4M$374.2M2.37×
Ttxa Ii 2022, LpSeries B$35.0M$369.6M2.34×
Encamp, Inc.Series B$54.0M$363.4M2.30×
JAF Communications Holdings, LLCSeries B$36.8M$358.9M2.27×
Enboarder Inc.Series B$39.7M$357.3M2.26×
Clade & Co., Inc. this companySeries B$15.7M$108.4M0.69×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$15.7M2024-01-22$87.2M$108.4M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$15.7M2024-01-22
    • First recorded raise — entered as Series B.
    • 32 investors on this round.
Intelligence
—
Modeled next raise
$25.1M
Modeled next size est.range $16.3M–$40.2M
—
Last step-up
—
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Gregory Racz——2024-01
Jan Oliver Koelble——2024-01
Jonathan Lipton——2024-01
Michael Oliver Stack——2024-01
Stephen Oliver George——2024-01
Registry & provenance

Clade & Co., Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
2009799
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
STAline Holdings, LLCOtherSeries B$15.4M$115.0Msame sector · same stage
Maybe Happy Ending Broadway Ltd Liability CoOtherSeries B$16.0M$102.4Msame sector · same stage
REDWOOD ONSTAGE Ltd LIABILITY CoOtherSeries B$16.0M$103.4Msame sector · same stage
I-O Urology CorpOtherSeries B$16.0M$113.2Msame sector · same stage
KCP KMC Holdings, LLCOtherSeries B$16.2M$104.4Msame sector · same stage
RWHC, The Broadway Musical LLCOtherSeries B$16.5M$107.6Msame sector · same stage
Spellcasters, Inc.OtherSeries B$16.5M$109.1Msame sector · same stage
Nuon Inc.OtherSeries B$16.6M$103.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Clade Therapeutics, Inc.PharmaceuticalsSeries C$1.1B80%
Indica, Inc.OtherPre-Seed$17.3M77%
Phytobiomed, Inc.OtherPre-Seed$3.6M77%
Revolutionary Growers LLCOtherSeed$8.3M77%
Flora Growth Corp.OtherSeries B$114.8M77%
True Botanicals, Inc.OtherSeries A$67.7M77%
RE Botanicals, Inc.OtherSeries A$88.9M76%
Botanical Investment Group, Inc.OtherSeries A$65.1M76%
Frequently asked
How much funding has Clade & Co., Inc. raised?
Clade & Co., Inc. has raised approximately $15.7M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is Clade & Co., Inc.'s estimated valuation?
Provath's modeled valuation for Clade & Co., Inc. is approximately $108.4M (modeled range $39.3M–$211.2M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Clade & Co., Inc. at?
Clade & Co., Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Mon Jan 22.
What does Clade & Co., Inc. do and where is it based?
Clade & Co., Inc. operates in the Other sector, based in NEW YORK.
Explore related

See where Clade & Co., Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Clade & Co., Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.